Research and Development Revenue (Details) - USD ($) $ in Thousands |
3 Months Ended | 6 Months Ended | |||
---|---|---|---|---|---|
Jun. 30, 2025 |
Jun. 30, 2024 |
Jun. 30, 2025 |
Jun. 30, 2024 |
Sep. 27, 2023 |
|
Research and Development Revenue [Line Items] | |||||
Awarded amount | $ 54,900 | ||||
Research and development expense | $ 6,600 | ||||
Cost of revenue | $ 2,775 | $ 4,164 | 6,314 | $ 7,545 | |
DHA [Member] | |||||
Research and Development Revenue [Line Items] | |||||
Awarded amount | $ 1,100 | 1,100 | |||
BARDA Contract [Member] | |||||
Research and Development Revenue [Line Items] | |||||
Research and development expense | 6,200 | 7,500 | |||
Cost of revenue | $ 300 | $ 2,200 |
X | ||||||||||
- Definition The aggregate cost of goods produced and sold and services rendered during the reporting period. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
X | ||||||||||
- Definition Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
X | ||||||||||
- Definition Amount of government assistance awarded that comprises amount received, receivable, and to be received unless condition for government assistance is not met. Includes, but is not limited to, government grant, assistance, incentive, award, subsidy, and loan. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
X | ||||||||||
- Definition Amount of expense for research and development. Includes, but is not limited to, cost for computer software product to be sold, leased, or otherwise marketed and writeoff of research and development assets acquired in transaction other than business combination or joint venture formation or both. Excludes write-down of intangible asset acquired in business combination or from joint venture formation or both, used in research and development activity. Reference 1: http://www.xbrl.org/2003/role/exampleRef
|
X | ||||||||||
- Details
|
X | ||||||||||
- Details
|